TY  - JOUR
AU  - Zhang, Haoran
AU  - Wu, Zhaozhen
AU  - Lu, Tao
AU  - Zhang, Hui
AU  - Li, Ji
AU  - Zhang, Dongming
AU  - Yu, Siyuan
AU  - Guo, Xiaobei
AU  - Feng, Xiaoyi
AU  - Liu, Jia
AU  - Shi, Yuequan
AU  - Gao, Xiaoxing
AU  - Liu, Xiaoyan
AU  - Chen, Minjiang
AU  - Zhao, Jing
AU  - Zhong, Wei
AU  - Hu, Ying
AU  - Xu, Yan
AU  - Wang, Mengzhao
PY  - 2025
TI  - Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study
JF  - Translational Lung Cancer Research; Vol 14, No 11 (November 30, 2025): Translational Lung Cancer Research
Y2  - 2025
KW  - 
N2  - 
UR  - https://tlcr.amegroups.org/article/view/108697